{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T01:31:56Z","timestamp":1762306316831,"version":"build-2065373602"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Coalition for Operational Research on Neglected Tropical Diseases","award":["NTD_SC_245\u00a0G"],"award-info":[{"award-number":["NTD_SC_245\u00a0G"]}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["BMGF OPP1053230"],"award-info":[{"award-number":["BMGF OPP1053230"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study aimed to validate the \u2018Engage &amp; Treat\u2019 (E&amp;T) and \u2018Test &amp; Treat\u2019 (T&amp;T) strategies to treat individuals who seldom or never participate in lymphatic filariasis mass drug administration (LF MDA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study was conducted in a hotspot district of Ghana, with 20 years of MDA. Treatment registers documenting participation were used to identify non-participating individuals. Individuals willingly accepting treatment were given the drugs (E&amp;T). Those who refused treatment were offered testing using the filaria test strip (FTS) and further engaged to receive treatment if positive (T&amp;T). A portion of the E&amp;T participants were also tested.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 25 068 individuals who missed the last MDA were identified; 93.13% accepted the drugs; 9958 people were tested, revealing an overall prevalence of 7.26% (95% CI 6.76 to 7.79%). Positivity was higher in T&amp;T (12.10%; 95% CI 10.43 to 13.92%) than in the E&amp;T group (6.47%; 95% CI 5.96 to 7.01%). The odds of testing positive were higher (OR=1.99; 95% CI 1.66 to 2.39; p&amp;lt;0.0001) among the T&amp;T population and missing three consecutive MDAs (OR=2.22; 95% CI 1.86 to 2.64; p&amp;lt;0.0001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The study confirms the validity of the strategies in addressing the challenges with non-treatment during LF MDA. Their implementation in areas of persistent transmission can support elimination in these settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/inthealth\/ihaf039","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T07:45:54Z","timestamp":1743493554000},"page":"960-967","source":"Crossref","is-referenced-by-count":0,"title":["Beyond business as usual for lymphatic filariasis mass drug administration in hotspot districts"],"prefix":"10.1093","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5000-6177","authenticated-orcid":false,"given":"Dziedzom K","family":"de Souza","sequence":"first","affiliation":[{"name":"University of Ghana Department of Parasitology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, , Accra ,","place":["Ghana"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey G","family":"Sumboh","sequence":"additional","affiliation":[{"name":"University of Ghana Department of Parasitology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, , Accra ,","place":["Ghana"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nii A","family":"Laryea","sequence":"additional","affiliation":[{"name":"University of Ghana Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, , Accra ,","place":["Ghana"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odame","family":"Asiedu","sequence":"additional","affiliation":[{"name":"Neglected Tropical Diseases Programme, Ghana Health Service , Accra ,","place":["Ghana"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bright","family":"Alomatu","sequence":"additional","affiliation":[{"name":"Neglected Tropical Diseases Programme, Ghana Health Service , Accra ,","place":["Ghana"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sedzro K","family":"Mensah","sequence":"additional","affiliation":[{"name":"University of Ghana Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, , Accra ,","place":["Ghana"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Otchere","sequence":"additional","affiliation":[{"name":"University of Ghana Department of Parasitology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, , Accra ,","place":["Ghana"]},{"name":"Klintaps College of Health & Allied Sciences , Klagon, Community 19, Tema ,","place":["Ghana"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph Larbi","family":"Opare","sequence":"additional","affiliation":[{"name":"Neglected Tropical Diseases Programme, Ghana Health Service , Accra ,","place":["Ghana"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Collins S","family":"Ahorlu","sequence":"additional","affiliation":[{"name":"University of Ghana Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, , Accra ,","place":["Ghana"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,4,12]]},"reference":[{"key":"2025110420273024200_bib1","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMe1811455","article-title":"Advancing toward the elimination of lymphatic filariasis","volume":"379","author":"Molyneux","year":"2018","journal-title":"N Engl J Med"},{"key":"2025110420273024200_bib2","first-page":"489","article-title":"Global programme to eliminate lymphatic filariasis: Progress report, 2022","volume":"41","author":"World Health Organization","year":"2023","journal-title":"Wkly Epidemiol Rec"},{"key":"2025110420273024200_bib3","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1365-3156.2000.00620.x","article-title":"Editorial: The Global Pl Programme to Eliminate Lymphatic Filariasis","volume":"5","author":"Ottesen","year":"2000","journal-title":"Trop Med Int Health"},{"issue":"Suppl 1","key":"2025110420273024200_bib4","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1093\/inthealth\/ihaa095","article-title":"Health economic analyses of the Global Programme to Eliminate Lymphatic Filariasis","volume":"13","author":"Turner","year":"2020","journal-title":"Int Health"},{"key":"2025110420273024200_bib5","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/inthealth\/ihaa061","article-title":"Setting the stage for a Global programme to eliminate Lymphatic filariasis: The first 125 years (1875\u20132000)","volume":"13","author":"Ottesen","year":"2020","journal-title":"Int Health"},{"key":"2025110420273024200_bib6","first-page":"1","article-title":"Alternative mass drug administration regimens to eliminate lymphatic filariasis","author":"World Health Organization","year":"2017"},{"key":"2025110420273024200_bib7","doi-asserted-by":"crossref","first-page":"e2447","DOI":"10.1371\/journal.pntd.0002447","article-title":"A review of factors that influence individual compliance with Mass Drug Administration for elimination of lymphatic filariasis","volume":"7","author":"Krentel","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"2025110420273024200_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/2049-9957-3-31","article-title":"Mass drug administration for lymphatic filariasis elimination in a coastal state of India: A study on barriers to coverage and compliance","volume":"3","author":"Hussain","year":"2014","journal-title":"Infect Dis Poverty"},{"key":"2025110420273024200_bib9","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.trstmh.2008.05.023","article-title":"Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: A mixed-methods study to identify factors associated with compliance and non-compliance","volume":"102","author":"Babu","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2025110420273024200_bib10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/bs.apar.2018.09.003","article-title":"Community and drug distributor perceptions and experiences of Mass Drug Administration for the elimination of lymphatic filariasis: A rapid review of qualitative research","volume":"103","author":"Ames","year":"2019","journal-title":"Adv Parasitol"},{"key":"2025110420273024200_bib11","first-page":"1","article-title":"Ending the neglect to attain the Sustainable Development Goals: A road map for neglected tropical diseases 2021\u20132030","author":"World Health Organization","year":"2020"},{"key":"2025110420273024200_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fitd.2022.953094","article-title":"Finding and eliminating the reservoirs: Engage and treat, and test and treat strategies for lymphatic filariasis programs to overcome endgame challenges","volume":"3","author":"de Souza","year":"2022","journal-title":"Front Trop Dis"},{"key":"2025110420273024200_bib13","first-page":"229","volume":"8(24)","author":"Kwadzo","year":"2017","journal-title":"The Impact of Postharvest Practices on the Poverty Status of Smallholder Cocoa Farmers. The Case of Ellembelle District in the Western Region of Ghana"},{"key":"2025110420273024200_bib14","doi-asserted-by":"crossref","first-page":"7044","DOI":"10.3390\/ijerph18137044","article-title":"An integrated approach to assess the environmental impacts of large-scale gold mining: The nzema-gold mines in the Ellembelle district of Ghana as a case study","volume":"18","author":"Kaku","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2025110420273024200_bib15","doi-asserted-by":"crossref","first-page":"e0011932","DOI":"10.1371\/journal.pntd.0011932","article-title":"Assessment of microfilaremia in \u2018hotspots\u2019 of four lymphatic filariasis endemic districts of Nepal during post-MDA surveillance","volume":"18","author":"Mehta","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"key":"2025110420273024200_bib16","doi-asserted-by":"crossref","first-page":"e0008301","DOI":"10.1371\/journal.pntd.0008301","article-title":"Risk factors associated with failing pre-transmission assessment surveys (Pre-TAS) in lymphatic filariasis elimination programs: Results of a multi-country analysis","volume":"14","author":"Burgert-Brucker","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"2025110420273024200_bib17","doi-asserted-by":"crossref","first-page":"e0002476","DOI":"10.1371\/journal.pgph.0002476","article-title":"Knowledge and perceptions of lymphatic filariasis patients in selected hotspot endemic communities in southern Ghana","volume":"3","author":"Kwarteng","year":"2023","journal-title":"PLOS Global Public Health"},{"key":"2025110420273024200_bib18","doi-asserted-by":"crossref","first-page":"e0262693","DOI":"10.1371\/journal.pone.0262693","article-title":"Lymphatic filariasis elimination status: Wuchereria bancrofti infections in human populations and factors contributing to continued transmission after seven rounds of mass drug administration in Masasi District, Tanzania","volume":"17","author":"Lupenza","year":"2022","journal-title":"PLoS One"},{"key":"2025110420273024200_bib19","doi-asserted-by":"crossref","first-page":"e0008927","DOI":"10.1371\/journal.pntd.0008927","article-title":"Lymphatic filariasis epidemiology in samoa in 2018: Geographic clustering and higher antigen prevalence in older age groups","volume":"14","author":"Lau","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"2025110420273024200_bib20","doi-asserted-by":"crossref","first-page":"e9927","DOI":"10.1371\/journal.pone.0009927","article-title":"Environmental factors associated with the distribution of Anopheles gambiae s.s in Ghana; an important vector of lymphatic filariasis and malaria","volume":"5","author":"de Souza","year":"2010","journal-title":"PLoS One"},{"key":"2025110420273024200_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4269\/ajtmh.18-0721","article-title":"Ecological and socioeconomic predictors of transmission assessment survey failure for lymphatic filariasis","volume":"101","author":"Goldberg","year":"2019","journal-title":"Am J Trop Med Hyg"},{"key":"2025110420273024200_bib22","doi-asserted-by":"crossref","first-page":"e0005027","DOI":"10.1371\/journal.pntd.0005027","article-title":"Improving coverage and compliance in Mass Drug Administration for the elimination of LF in two \u201cendgame\u201d districts in Indonesia using micronarrative surveys","volume":"10","author":"Krentel","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"2025110420273024200_bib23","doi-asserted-by":"crossref","first-page":"e0010900","DOI":"10.1371\/journal.pntd.0010900","article-title":"Assessment of factors related to individuals who were never treated during mass drug administration for lymphatic filariasis in Ambon City, Indonesia","volume":"16","author":"Titaley","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"2025110420273024200_bib24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13071-021-04583-y","article-title":"Risk factors for lymphatic filariasis and mass drug administration non-participation in Mandalay Region, Myanmar","volume":"14","author":"Dickson","year":"2021","journal-title":"Parasit Vectors"},{"key":"2025110420273024200_bib25","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/molbev\/msz116","article-title":"Human migration and the spread of the nematode parasite Wuchereria bancrofti","volume":"36","author":"Small","year":"2019","journal-title":"Mol Biol Evol"},{"key":"2025110420273024200_bib26","first-page":"133","article-title":"The epidemiology of lymphatic filariasis in Ghana, explained by the possible existence of two strains of Wuchereria bancrofti","volume":"17","author":"de Souza","year":"2014","journal-title":"Pan Afr Med J"},{"key":"2025110420273024200_bib27","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.3390\/buildings13092288","article-title":"The impact of resettlement on quality of life in Ghana: The mediating role of residential satisfaction","volume":"13","author":"Boadi","year":"2023","journal-title":"Buildings"},{"key":"2025110420273024200_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3368\/gs.22.1.3","article-title":"Political economy of internal migration and labor-seeking behavior of poor youth in Ghana","volume":"22","author":"Assan","year":"2019","journal-title":"Ghana Studies"},{"key":"2025110420273024200_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40249-020-0638-1","article-title":"The fight against lymphatic filariasis: Perceptions of community drug distributors during mass drug administration in coastal Kenya","volume":"9","author":"Kusi","year":"2020","journal-title":"Infect Dis Poverty"},{"key":"2025110420273024200_bib30","doi-asserted-by":"crossref","first-page":"e0012213","DOI":"10.1371\/journal.pntd.0012213","article-title":"Modelling the cost of engage & treat and test & treat strategies towards the elimination of lymphatic filariasis in Ghana","volume":"18","author":"Adams","year":"2024","journal-title":"PLoS Negl Trop Dis"}],"container-title":["International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/inthealth\/article-pdf\/17\/6\/960\/62920584\/ihaf039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/inthealth\/article-pdf\/17\/6\/960\/62920584\/ihaf039.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T01:27:42Z","timestamp":1762306062000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/inthealth\/article\/17\/6\/960\/8112535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,12]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,4,12]]},"published-print":{"date-parts":[[2025,11,4]]}},"URL":"https:\/\/doi.org\/10.1093\/inthealth\/ihaf039","relation":{},"ISSN":["1876-3413","1876-3405"],"issn-type":[{"type":"print","value":"1876-3413"},{"type":"electronic","value":"1876-3405"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,4,12]]}}}